Quotient Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Quotient Investors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,300	Closed	-$909K	–	203
2016 Q3	$909K	Sell	7,300 -1,700	-19%	-$201K	0.59%	61
2016 Q2	$957K	Sell	9,000 -2,240	-20%	-$260K	0.45%	78
2016 Q1	$1.29M	Buy	+11,240	New	+$1.32M	0.47%	76

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Quotient Investors's CBPO Position: Q4 2016 in Review

Quotient Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2016, closing a stake of 7,300 shares — an estimated $909K sold.

Quotient Investors first reported a position in CBPO in Q1 2016 and held it in 3 quarters. The position peaked at $1.29M in Q1 2016. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

Quotient Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Quotient Investors sold 7,300 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $909K.
Quotient Investors first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 3 quarters.
Quotient Investors's China Biologic Products Holdings, Inc. position peaked at $1.29M in Q1 2016.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on Quotient Investors's 13F filing for Q4 2016, filed 25 Jan 2017.